Regulatory networks defining EMT during cancer initiation and progression
Open accessThe DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Abstract
Epithelial to mesenchymal transition (EMT) is essential for driving plasticity during development, but is an unintentional behaviour of cells during cancer progression. The EMT-associated reprogramming of cells not only suggests that fundamental changes may occur to several regulatory networks but also that an intimate interplay exists between them. Disturbance of a controlled epithelial balance is triggered by altering several layers of regulation, including the transcriptional and translational machinery, expression of non-coding RNAs, alternative splicing and protein stability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In cancer, EMT plays an important role in tumor invasion, metastasis, and resistance to various therapies [75].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [75]
Citations
Cites
1 retracted
RETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3
Herranz, N., Dave, N., Millanes‐Romero, A., Morey, L., Diaz, V. M., Lorenz, V., Gallego, R. G., Jerónimo, C., Croce, L. D., de Herreros, A. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.002 · Cited by 80
RetractedEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Cited by
Items 401–500 of 1,004
Reversal of myofibroblast differentiation: A review
Yang, X., Chen, B., Liu, T., & Chen, X. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.04.007 · Cited by 89
Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis
Yuan, X., Zhang, M., Wu, H. K., Xu, H., Han, N., Chu, Q., Yu, S., Chen, Y., & Wu, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131689 · Cited by 92
“Multiple signaling molecules, including epithelial growth factor receptor (EGFR), vascular endothelial growth factor (VEGFR) and transforming growth factor β (TGF-β), participate in the metastatic process [30].”
BackgroundDlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch
Lee, S. Y., Jeon, H. M., Ju, M. K., Jeong, E. K., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2016) · Oncotarget · doi:10.18632/oncotarget.6879 · Cited by 85
“com/oncotarget of epithelial proteins, such as E-cadherin, and increases in levels of mesenchymal proteins, such as vimentin, that upregulate mesenchymal migration and invasion [19, 22].”
BackgroundCantoni, C., Huergo-Zapico, L., Parodi, M., Pedrazzi, M., Mingari, M. C., Moretta, A., Sparatore, B., Gonzalez, S. R., Olive, D., Bottino, C., et al. (2016) · Journal of Immunology Research · doi:10.1155/2016/4684268 · Cited by 91
“Acquisition of migrating and”
Ji, Y., Yang, C., Tang, Z., Yang, Y., Tian, Y., Yao, H., Zhu, X. D., Zhang, Z., Ji, J., & Zheng, X. (2017) · Nature Communications · doi:10.1038/ncomms15308 · Cited by 90
Majc, B., Sever, T., Zarić, M., Breznik, B., Turk, B., & Lah, T. T. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118782 · Cited by 83
Trim28 Contributes to EMT via Regulation of E-Cadherin and N-Cadherin in Lung Cancer Cell Lines
Chen, L., Muñoz-Antonia, T., & Cress, W. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101040 · Cited by 89
“Like many other biological processes, EMT is ultimately regulated transcriptionally by a number of transcription factors such as Snail1, Snail2, ZEB1 and ZEB2 [4].”
BackgroundPotential Anti-metastasis Natural Compounds for Lung Cancer
Chanvorachote, P., Chamni, S., Ninsontia, C., & Phiboonchaiyanan, P. P. (2016) · Anticancer Research · doi:10.21873/anticanres.11154 · Cited by 87
Rodriguez, D. A., Ramkairsingh, M., Lin, X., Kapoor, A., Major, P. P., & Tang, D. (2019) · Cancers · doi:10.3390/cancers11071028 · Cited by 85
“While the contributions of these ESR1 function genes in BCSC acquisition during ETR remain to be directly demonstrated, ectopic expression of either ESR1-YAP1 or ESR1-PCDH11X in T47D cells conferred resistance to fulvestrant with concurrent enrichment in the ER and EMT processes [113].”
BackgroundInfluentialIchikawa, K., Kubota, Y., Nakamura, T., Weng, J. S., Tomida, T., Saito, H., & Takekawa, M. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.023 · Cited by 91
Kinugasa, H., Whelan, K. A., Tanaka, K., Natsuizaka, M., Long, A., Guo, A. J., Chang, S., Kagawa, S., Srinivasan, S., Guha, M., et al. (2015) · Oncogene · doi:10.1038/onc.2014.449 · Cited by 86
Guo, F., Cogdell, D. E., Hu, L., Yang, D., Sood, A. K., Xue, F., & Zhang, W. (2014) · Oncology Reports · doi:10.3892/or.2014.3106 · Cited by 84
“The epithelial-to-mesenchymal transition (EMT) has been recognized as an important physiological process that is associated with cancer progression and metastasis in multiple epithelial cancer types, including ovarian carcinoma (3).”
BackgroundPuppo, M., Bucci, G., Rossi, M. S., Giovarelli, M., Bordo, D., Moshiri, A., Gorlero, F., Gherzi, R., & Briata, P. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.055 · Cited by 93
Li, D., Qu, C., Ning, Z., Wang, H., Zang, K., Zhuang, L., Chen, L., Wang, P., & Meng, Z. (2016) · PubMed · Cited by 101
Cortés‐Hernández, L. E., Eslami‐S, Z., & Alix‐Panabières, C. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.07.008 · Cited by 88
Pituitary tumors contain a side population with tumor stem cell-associated characteristics
Mertens, F., Gremeaux, L., Chen, J., Fu, Q., Willems, C., Roose, H., Govaere, O., Roskams, T., Cristina, C., Becú‐Villalobos, D., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0546 · Cited by 87
PROP1 triggers epithelial-mesenchymal transition-like process in pituitary stem cells
Millan, M. I. P., Brinkmeier, M. L., Mortensen, A. H., & Camper, S. A. (2016) · eLife · doi:10.7554/elife.14470 · Cited by 85
“EMT plays an important role in cancer pathogenesis, partic- ularly during growth, maintenance and progression of the tumor with local invasion or metastasis (De Craene and Berx, 2013; Pirozzi et al., 2011; Mani et al., 2008).”
BackgroundThe role of epithelial-mesenchymal transition in regulating radioresistance
Zhou, S., Zhang, M., Chao Hui, Z. H. O. U., Wang, W., Yang, H., & Ye, W. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102961 · Cited by 81
SNAI2 Controls the Undifferentiated State of Human Epidermal Progenitor Cells
Mistry, D. S., Chen, Y., Wang, Y., Zhang, K., & Sen, G. L. (2014) · Stem Cells · doi:10.1002/stem.1809 · Cited by 90
Pal, H. C., Diamond, A. C., Strickland, L. R., Kappes, J. C., Katiyar, S. K., Elmets, C. A., Athar, M., & Afaq, F. (2016) · Oncotarget · doi:10.18632/oncotarget.6237 · Cited by 79
“This then leads to upregulated MMPs, which further activates EMT transcription factors in a feed-forward loop [53].”
García‐Palmero, I., Torres, S., Bartolomé, R. A., Peláez‐García, A., Larriba, M. J., López-Lucendo, M. F., Peña, C., Escudero-Paniagua, B., Múñoz, A., & Casal, J. I. (2016) · Oncogene · doi:10.1038/onc.2016.57 · Cited by 79
Pluripotent Stem Cell miRNAs and Metastasis in Invasive Breast Cancer
Volinia, S., Nuovo, G. J., Drusco, A., Costinean, S., Abujarour, R., Desponts, C., Garofalo, M., Baffa, R., Aeqilan, R., Maharry, K. S., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju324 · Cited by 79
Cao, Y. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0188-9 · Cited by 94
Singh, S., & Chakrabarti, R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050642 · Cited by 79
“Claudin-low tumors are high in stem-cell-associated processes and display high expression of genes involved in EMT [22,23].”
BackgroundLee, Y., Yoon, J., Ko, D., Yu, M., Lee, S., & Kim, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02147-7 · Cited by 78
“To induce EMT and invasiveness, TWIST1 directly or indirectly represses E-cadherin transcription through E-box elements in the E-cadherin promoter [7].”
BackgroundThe Rb–E2F Transcriptional Regulatory Pathway in Tumor Angiogenesis and Metastasis
Schaal, C. M., Pillai, S., & Chellappan, S. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00004-4 · Cited by 82
Reprogramming during epithelial to mesenchymal transition under the control of TGFβ
Tan, E., Olsson, A.-K., & Moustakas, A. (2014) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.983794 · Cited by 91
“In an inducible EMT model, Javaid et. al analyzed the chromatin dynamics upon Snail1 activation in human mammary epithelial cells and found that Snail1 represses epithelial genes at the early phase of EMT and sustained Snail1 expression activates mesenchymal genes at the late stage of EMT.112 The short time frame duri…”
BackgroundInfluentialRen, T., Zhang, W., Liu, X., Zhao, H., Zhang, J., Zhang, J., Li, X., Zhang, Y., Bu, X., Shi, M., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4415 · Cited by 79
Gao, H., Teng, C.-Y., Huang, W., Peng, J.-J., & Wang, C.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160921643 · Cited by 76
“to be regulated by well coordinated actions of a number of proteins that are strategically localized in nuclear and cytosolic compartments [15].”
BackgroundIn Vitro Modeling of Mechanics in Cancer Metastasis
Malandrino, A., Kamm, R. D., & Moeendarbary, E. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00041 · Cited by 84
miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells
Liu, C., Guan, H., Wang, Y., Chen, M., Xu, B., Zhang, L., Lǚ, K., Tao, T., Zhang, X., & Huang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144073 · Cited by 77
“Epithelial-mesenchymal transition (EMT), known to turn epithelial cells into mesenchymal cells, also performs crucial functions in cancer metastasis [6].”
BackgroundPan, Y., Chen, J., Tao, L., Zhang, K., Wang, R., Chu, X., & Chen, L. (2017) · Oncotarget · doi:10.18632/oncotarget.16562 · Cited by 78
“Emerging evidence indicates a close relationship between chemoresistance and EMT process in cancer [5].”
BackgroundLeBert, D. C., Squirrell, J. M., Freisinger, C., Rindy, J., Golenberg, N., Frecentese, G., Gibson, A. L. F., Eliceiri, K. W., & Huttenlocher, A. (2018) · eLife · doi:10.7554/elife.30703 · Cited by 85
“The intermediate filament protein vimentin is expressed during EMT and provides a marker of EMT during cell transformation (De Craene and Berx, 2013).”
BackgroundJin, Y., Zhang, Y., Li, B., Zhang, J., Dong, Z., Hu, X., & Wan, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.269 · Cited by 80
Adhikari, M., Kaushik, N., Ghimire, B., Adhikari, B., Baboota, S., Al-Khedhairy, A. A., Wahab, R., Lee, S., Kaushik, N. K., & Choi, E. H. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0360-4 · Cited by 78
Cao, Y., Wang, X., Li, Y., Evers, M., Zhang, H., & Chen, X. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0973-0 · Cited by 83
Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution
Francescangeli, F., Angelis, M. L. D., Rossi, R., Cuccu, A., Giuliani, A., Maria, R. D., & Zeuner, A. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10092-4 · Cited by 113
“SNAI1, SNAI2, ZEB1, ZEB2, and TWIST1 are the main transcription factors that orchestrate EMT and repress epithelial programs [42, 43].”
BackgroundMelanoma Cells Revive an Embryonic Transcriptional Network to Dictate Phenotypic Heterogeneity
Vandamme, N., & Berx, G. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00352 · Cited by 78
“The extensive interplay between Zeb transcription factors and members of the TGF-β family in normal and pathological context of epithelial cells is well established (3, 31).”
Self-citationSu, L., Luo, Y., Yang, Z., Yang, H. J., Yao, C., Cheng, F., Shan, J., Chen, J., Li, F., Liu, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0246 · Cited by 78
Schierbaum, N., Rheinlaender, J., & Schäffer, T. E. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.04.006 · Cited by 77
Multifaceted roles of HSF1 in cancer
Jiang, S., Tu, K., Fu, Q., Schmitt, D. C., Zhou, L., Lu, N., & Zhao, Y. (2015) · Tumor Biology · doi:10.1007/s13277-015-3674-x · Cited by 79
“EMT facilitates the migration of epithelial tumor cells from the primary tumor site to distant locations and is an essential step for tumor progression and metastasis [48].”
BackgroundWang, X., Zhang, G., Cheng, Z., Dai, L., Jia, L., Jing, X., Wang, H., Zhang, R., Liu, M., Jiang, T., et al. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2018.0026 · Cited by 75
“EMTisacrucial event that occurs during cancer metastasis (Kang and Massague, 2004), and studies have identified distinct signaling pathways that regulate EMT (De Craene and Berx, 2013).”
Breast cancer brain metastasis: Current evidence and future directions
Sun, H., Xu, J., Dai, S., Ma, Y., & Sun, T. (2022) · Cancer Medicine · doi:10.1002/cam4.5021 · Cited by 84
Chiaro, P. D., Nacci, L., Arco, F., Brandini, S., Polletti, S., Palamidessi, A., Donati, B., Soriani, C., Gualdrini, F., Frigè, G., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.02.017 · Cited by 87
Metastasis regulation by PPARD expression in cancer cells
Zuo, X., Xu, W., Xu, M., Tian, R., Moussalli, M. J., Mao, F., Zheng, X., Wang, J., Morris, J. S., Gagea, M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91419 · Cited by 88
Multiple modes of action of eribulin mesylate: Emerging data and clinical implications
Cortés, J., Schöffski, P., & Littlefield, B. A. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.08.008 · Cited by 81
Vantaku, V., Putluri, V., Bader, D. A., Maity, S., Ma, J., Arnold, J. M., Rajapakshe, K., Donepudi, S. R., von Rundstedt, F.-C., Devarakonda, V., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0902-7 · Cited by 95
Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells
Yoh, K. E., Regunath, K., Guzman, A., Lee, S.-M., Pfister, N. T., Akanni, O., Kaufman, L. J., Prives, C., & Prywes, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613417113 · Cited by 75
“Canonical transcription factors that repress E-cadherin include Twist, Snail, Slug, and Zeb1, although this network has grown more complex in recent years (14, 15).”
BackgroundHistone Methyltransferase hSETD1A Is a Novel Regulator of Metastasis in Breast Cancer
Salz, T., Deng, C., Pampo, C., Siemann, D. W., Qiu, Y., Brown, K. D., & Huang, S. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0389 · Cited by 77
“Compelling evidence indicating alterations in histone modification patterns during cancer initiation, progression, and metastasis has fueled speculation concerning the role of histone-modifying enzymes in tumorigenesis (25, 35, 52).”
BackgroundEphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance
Depner, C., Buttel, H. Z., Böğürcü, N., Cuesta, Á. M., Aburto, M. R., Seidel, S., Finkelmeier, F., Foss, F., Hofmann, J., Kaulich, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms12329 · Cited by 81
Wu, Y., Zhou, Y., Huan, L., Xu, L., Shen, M., Huang, S., & Liang, L. (2019) · Cancer Science · doi:10.1111/cas.13950 · Cited by 78
Tian, Y., Ma, R., Sun, Y., Liu, H., Zhang, H., Sun, Y., Liu, L., Li, Y., Song, L., & Gao, P. (2020) · Oncogene · doi:10.1038/s41388-020-1330-4 · Cited by 82
Wu, K., Xu, H., Yuan, X., Tian, Y., Liu, Y., Liu, Q., Wu, H. K., & Wu, G. S. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s97192 · Cited by 86
“Breast cancer metastasis is a complicated process which is involved in the alteration of a number of proteins, including epithelial growth factor receptor and transforming growth factor-β.(92) Considering the complex regulation of the metastasis process of breast cancer, the effects of CD44 on the MFS might be covered…”
Tarbet, H. J., Dolat, L., Smith, T. J., Condon, B. M., O’Brien, E. T., Valdivia, R. H., & Boyce, M. (2018) · eLife · doi:10.7554/elife.31807 · Cited by 80
“DOI: https://doi.org/10.7554/eLife.31807 2 of 29 transition, and is widely observed in human metastatic cancers (Satelli and Li, 2011; Nieto, 2011; De Craene and Berx, 2013).”
BackgroundInfluentialRoche, J., Nasarre, P., Gemmill, R. M., Baldys, A., Pontis, J., Korch, C. T., Guilhot, J., Ait‐Si‐Ali, S., & Drabkin, H. A. (2013) · Cancers · doi:10.3390/cancers5020334 · Cited by 84
Novel clinical therapeutics targeting the epithelial to mesenchymal transition
Kothari, A. N., Mi, Z., Zapf, M. A. C., & Kuo, P. C. (2014) · Clinical and Translational Medicine · doi:10.1186/s40169-014-0035-0 · Cited by 84
“Non-coding RNAs Non-coding RNAs and, in particular, microRNAs (miRNAs) have gained significant attention for their ability to modify gene expression allowing for quick cellular adaptation to new environments and conditions [29,40].”
BackgroundLiu, F., Cai, Y., Rong, X., Chen, J., Zheng, D., Chen, L., Zhang, J., Luo, R., Zhao, P., & Ruan, J. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0698-4 · Cited by 74
“Epithelial-to-mesenchymal transition (EMT), a key process characterized by molecule rearrangement and cellular phenotype alternation [26, 27], is usually correlated with poor prognosis, higher metastasis rate and shorter disease free survival [28].”
Intravital microscopy of collective invasion plasticity in breast cancer
Ilina, O., Campanello, L., Gritsenko, P. G., Vullings, M., Wang, C., Bult, P., Losert, W., & Friedl, P. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.034330 · Cited by 85
“Because single-cell events are enhanced in epithelial tumors when E-cadherin is downregulated (Khalil et al., 2017), E-cadherin was initially considered to counteract local tissue invasion and metastatic spread (De Craene and Berx, 2013).”
BackgroundPathogenesis of periodontitis – A potential role for epithelial-mesenchymal transition
Saliem, S. S., Bede, S. Y. H., Cooper, P. R., Abdulkareem, A. A., Milward, M. R., & Abdullah, B. H. (2022) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2022.09.001 · Cited by 83
“pressed and this is also implicated in the loss of epithelial junctions and adhesions [112,123,124].”
BackgroundHan, S., Wang, D., Huang, Y., Zeng, Z., Xu, P., Xiong, H., Ke, Z., Zhang, Y., Hu, Y., Wang, F., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02556-2 · Cited by 80
SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT
Liu, W., Wang, X., Wang, Y., Dai, Y., Xie, Y., Ping, Y., Yin, B., Yu, P., Liu, Z., Duan, X., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0743-1 · Cited by 74
“The EMT/MET processes are regulated by a number of factors, among which the SNAI family members Snail and Slug are known to repress E-cadherin expression in epithelial cells undergoing EMT, but no evidences exist on their roles on other members of the cadherin family, neither additional roles on target genes [3, 7, 8].”
Elisha, Y., Kalchenko, V., Kuznetsov, Y., & Geiger, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-22940-3 · Cited by 87
The epithelial–mesenchymal transition (EMT) is regulated by oncoviruses in cancer
Xue, C., Bode, A. M., Dong, Z., & Cao, Y. (2016) · The FASEB Journal · doi:10.1096/fj.201600388r · Cited by 73
Xie, H.-Y., Shao, Z., & Li, D. (2017) · 癌症:英文版 · doi:10.1186/s40880-017-0202-y · Cited by 79
Song, Y., Li, Z., Liu, X., Wang, R., Li, L.-W., & Zhang, Q. (2017) · Tumor Biology · doi:10.1177/1010428317712617 · Cited by 79
Bhatia, S., Monkman, J. H., Toh, A. K. L., Nagaraj, S. H., & Thompson, E. W. (2017) · Biochemical Journal · doi:10.1042/bcj20160782 · Cited by 79
Puls, T. J., Tan, X., Whittington, C. F., & Voytik‐Harbin, S. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188870 · Cited by 78
Boulding, T., Wu, F., McCuaig, R., Dunn, J., Sutton, C. R., Hardy, K., Tu, W., Bullman, A., Yip, D., Dahlstrom, J. E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148065 · Cited by 76
“EMT has been implicated in cancer initiation, progression, metastasis, resistance to conventional therapies, and recurrence [4].”
BackgroundKitazawa, K., Hikichi, T., Nakamura, T., Mitsunaga, K., Tanaka, A., Nakamura, M., Yamakawa, T., Furukawa, S., Takasaka, M., Goshima, N., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.020 · Cited by 73
Matsumoto, R., Tsuda, M., Yoshida, K., Tanino, M. A., Kimura, T., Nishihara, H., Abe, T., Shinohara, N., Nonomura, K., & Tanaka, S. (2016) · Scientific Reports · doi:10.1038/srep34625 · Cited by 78
Yamada, N., Sugai, T., Eizuka, M., Tsuchida, K., Sugimoto, R., Mue, Y., Suzuki, M., Osakabe, M., Uesugi, N., Ishida, K., et al. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.10.007 · Cited by 76
Kodama, T., Newberg, J. Y., Kodama, M., Rangel, R., Yoshihara, K., Tien, J. C.-Y., Parsons, P. H., Wu, H., Finegold, M. J., Copeland, N. G., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606876113 · Cited by 81
“Am J Physiol Cell Physiol 292(6):C2288–C2296.”
BackgroundInfluentialJolly, M. K., Preca, B., Tripathi, S. C., Jia, D., George, J. T., Hanash, S., Brabletz, T., Stemmler, M. P., Maurer, J., & Levine, H. (2018) · APL Bioengineering · doi:10.1063/1.5024874 · Cited by 74
Jia, D., Li, X., Bocci, F., Tripathi, S., Deng, Y., Jolly, M. K., Onuchic, J. N., & Levine, H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050725 · Cited by 84
Li, J., Chong, T., Wang, Z., Chen, H., LI, H., Cao, J., Zhang, P., & Li, H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2417 · Cited by 72
“Epithelial-mesenchymal transition (EMT) is a fundamental process of embryogenesis; however, it is also associated with the progression of a number of different types of cancer (4-6).”
Chen, Z.-J., Wei, W., Jiang, G.-M., Liu, H., Wei, W.-D., Yang, X., Wu, Y.-M., Liu, H., Wong, C. K. C., Du, J., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.002 · Cited by 83
“The progression of EMTs can be regulated by several important transcription factors such as Snail, Slug, Twist and Zeb (Thiery et al., 2009), followed by the convergence of the multiple signaling pathways such as MAPK, PI3K, and NF-kB (Craene and Berx, 2013; Tiwari et al., 2012).”
BackgroundJeon, Y. K., Kim, C. K., Hwang, K., Park, H.-Y., Koh, J., Chung, D. H., Lee, C., & Ha, G. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.143 · Cited by 72
“mutants Akt underwent EMT along with Snail and Slug activation.(2,12,51) ERK signaling also upregulated the expression of Snail and Slug in lung cancer.”
BackgroundTivari, S., Lü, H., Dasgupta, T., Lorenzo, M. S. D., & Wieder, R. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0259-5 · Cited by 73
IGFBP2 in cancer: Pathological role and clinical significance (Review)
Wei, L., Weng, X., Huang, X., Peng, Y., Guo, H., & Xu, Y. (2020) · Oncology Reports · doi:10.3892/or.2020.7892 · Cited by 71
“Epithelial-to-mesenchymal transition (EMT) plays a vital role in tumorigenesis (65).”
BackgroundBłaszczak, E., Miziak, P. A., Odrzywolski, A., Baran, M. T., Gumbarewicz, E., & Stepulak, A. (2025) · Cancers · doi:10.3390/cancers17020228 · Cited by 82
“The expression of N-cadherin is regulated by several EMT-associated transcription factors, such as Snail, Slug, and Twist, which repress epithelial markers while activating mesenchymal markers [66,121].”
The Tumor Border Configuration of Colorectal Cancer as a Histomorphological Prognostic Indicator
Koelzer, V. H., & Lugli, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00029 · Cited by 77
“Biologically, tumor budding is likely the visible correlate of the process of epithelial mesenchymal transition, during which cancer cells, epithelial by nature, acquire mesenchymal characteristics with capability for migration, stromal lysis, and vascular invasion (28).”
BackgroundNasarre, P., Gemmill, R. M., Potiron, V. A., Roche, J., Lu, X. J. D., Barón, A. E., Korch, C. T., Garrett-Mayer, E. S., Laganà, A., Howe, P. H., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1755 · Cited by 80
“The epithelialmesenchymal transition (EMT), by which epithelial cells acquire a mesenchymal and invasive phenotype, contributes significantly to these barriers (1).”
Cheng, Q., Chang, J. T., Gwin, W. R., Zhu, J., Ambs, S., Geradts, J., & Lyerly, H. K. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0407-9 · Cited by 74
“The top activated pathways of these 51 genes were ECM remodeling, fibrosis and EMT signaling (TWIST1, JAG1, SNAI2 [30]), indicating the correlation between EMT and stromal activation in primary tumor with high risk of late recurrence (Additional file 4).”
InfluentialTumor budding as a standardized parameter in gastrointestinal carcinomas: more than just the colon
Berg, K. B., & Schaeffer, D. F. (2018) · Modern Pathology · doi:10.1038/s41379-018-0028-4 · Cited by 76
“Another hypothesis suggests that although tumor buds exhibit E-cadherin downregulation, they do not share other regulatory changes common to the epithelial–mesenchymal transition and that the budding phenotype may occur by another mechanism [5, 6].”
BackgroundHorimoto, Y., Tokuda, E., Murakami, F., Uomori, T., Himuro, T., Nakai, K., Orihata, G., Iijima, K., Togo, S., Shimizu, H., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1663-8 · Cited by 73
Connexins, gap junctions and tissue invasion
Defamie, N., Chépied, A., & Mesnil, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.01.012 · Cited by 81
“And it has been reported in many models that tumor progression in invasive and metastatic stages is associated with cellular dedifferentiation, cell polarity alteration and acquisition of fibroblastoid morphology [73–75].”
BackgroundLiu, W., Jiang, D., Gong, F., Huang, Y., Luo, Y., Rong, Y., Wang, J., Ge, X., Ji, C., Fan, J., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2270-1 · Cited by 78
Xu, R., Yang, J., Ren, B., Wang, H., Yang, G., Chen, Y., You, L., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.572722 · Cited by 78
“It has been demonstrated that Zeb1 promotes pancreatic tumor progression from formation of early precursor lesions toward late-stagemetastasis in contrast to EMT-TFs Snai1 and Twist1, which suggests that different EMT-TFs have specific and complementary subfunctions in driving pancreatic tumor metastasis (100, 101).”
BackgroundThe Roles of H19 in Regulating Inflammation and Aging
Wang, B., Suen, C.-W. W., Ma, H., Wang, Y., Kong, L. D., Qin, D., Lee, W., & Li, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579687 · Cited by 78
“The EMT also contributes to the progression and metastasis of cancer cells, and is involved in suppressing cell senescence and in developing resistance to radiotherapy and chemotherapy (52, 53).”
BackgroundRNA binding proteins in the regulation of heart development
Blech-Hermoni, Y. N., & Ladd, A. N. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.08.008 · Cited by 78
“Binding upstream of an exon leads to skipping of that exon, while binding downstream of an exon leads to its inclusion (De Craene and Berx, 2013).”
BackgroundTargeting Platelets for the Treatment of Cancer
Elaskalani, O., Berndt, M., Falasca, M., & Metharom, P. (2017) · Cancers · doi:10.3390/cancers9070094 · Cited by 77
A core microRNA signature associated with inducers of the epithelial‐to‐mesenchymal transition
Díaz‐Martín, J., Díaz‐López, A., Moreno‐Bueno, G., Castilla, M. Á., Rosa-Rosa, J. M., Cano, A., & Palacios, J. (2013) · The Journal of Pathology · doi:10.1002/path.4289 · Cited by 78
“EMT-TFs have been reported to interact with histone-modifying complexes, ultimately affecting chromatin remodelling [9,49].”
BackgroundLi, A., Li, D., Chu, H.-X., Zhang, Q., Wang, C., Fan, Y., Song, Q., Ma, H., Feng, F., & Zhao, Q. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.07.021 · Cited by 74
Emerging role of Twist1 in fibrotic diseases
Ning, X., Zhang, K., Wu, Q., Liu, M., & Sun, S. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13465 · Cited by 69
“The EMT program is regulated at multiple levels, and it is modulated mainly by various post-transcriptional, translational and post-translational regulators [32, 33].”
BackgroundNF-κB, Mesenchymal Differentiation and Glioblastoma
Yamini, B. (2018) · Cells · doi:10.3390/cells7090125 · Cited by 77
“In general, mesenchymal transition involves loss of the epithelial marker, E-cadherin, and concomitant increase in mesenchymal factors, N-cadherin and vimentin (VIM) [3].”
BackgroundLee, S. Y., Ju, M. K., Jeon, H., Lee, Y. S., Kim, C. H., Park, H., Han, S. I., & Kang, H. Y. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10466 · Cited by 92
KDM1 class flavin‐dependent protein lysine demethylases
Burg, J. M., Link, J. E., Morgan, B. S., Heller, F. J., Hargrove, A. E., & McCafferty, D. G. (2015) · Biopolymers · doi:10.1002/bip.22643 · Cited by 75
Multifaceted Interpretation of Colon Cancer Stem Cells
Hatano, Y., Fukuda, S., Hisamatsu, K., Hirata, A., Hara, A., & Tomita, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071446 · Cited by 76
“EMT inducers prompt the loss of E-cadherin, which is the initial step in transformation from the epithelial to mesenchymal phenotype [85].”
BackgroundYun, S., Han, S., & Park, J. (2018) · PPAR Research · doi:10.1155/2018/6727421 · Cited by 74
STIM-Orai Channels and Reactive Oxygen Species in the Tumor Microenvironment
Frisch, J., Angenendt, A., Hoth, M., Prates Roma, L., & Lis, A. (2019) · Cancers · doi:10.3390/cancers11040457 · Cited by 68
“Additionally, the indispensable change in gene expression is activated by complex regulatory networks, involving transcriptional control, transcriptional factors, miRNAs, alternative splicing, posttranslational regulation, protein stability, and subcellular localization [78].”
Background
Metadata
- Authors
- Craene, B. D., & Berx, G.
- Affiliations
- Ghent University (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Berx, Geert
- ORCID
- Berx, Geert
- Venue
- Nature Reviews Cancer
- Published
- 2013-01-24
- Volume
- 13
- Issue
- 2
- Pages
- 97-110
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2016360721
- Cited by
- 2,487
- References
- 205
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 127 · 2023: 159 · 2022: 209 · 2021: 247 · 2020: 260 · 2019: 239 · 2018: 234 · 2017: 253 · 2016: 202 · 2015: 181 · 2014: 182 · 2013: 83
- FWCI
- 22.16
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, tumor progression, tumor initiation, cellular plasticity, transcriptional regulation, translational regulation, non-coding RNA, alternative splicing, protein stability
- MeSH terms
- Animals, Epithelial Cells, Humans, Neoplasms, Disease Progression, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.